185 related articles for article (PubMed ID: 27012853)
1. Direct Medical Costs Attributable to Cancer-Associated Venous Thromboembolism: A Population-Based Longitudinal Study.
Cohoon KP; Ransom JE; Leibson CL; Ashrani AA; Petterson TM; Long KH; Bailey KR; Heit JA
Am J Med; 2016 Sep; 129(9):1000.e15-25. PubMed ID: 27012853
[TBL] [Abstract][Full Text] [Related]
2. Costs of venous thromboembolism associated with hospitalization for medical illness.
Cohoon KP; Leibson CL; Ransom JE; Ashrani AA; Petterson TM; Long KH; Bailey KR; Heit JA
Am J Manag Care; 2015 Apr; 21(4):e255-63. PubMed ID: 26244788
[TBL] [Abstract][Full Text] [Related]
3. Direct medical costs attributable to venous thromboembolism among persons hospitalized for major operation: a population-based longitudinal study.
Cohoon KP; Leibson CL; Ransom JE; Ashrani AA; Park MS; Petterson TM; Long KH; Bailey KR; Heit JA
Surgery; 2015 Mar; 157(3):423-31. PubMed ID: 25633736
[TBL] [Abstract][Full Text] [Related]
4. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries.
Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Schein J; Kaatz S
J Manag Care Pharm; 2012 Jun; 18(5):363-74. PubMed ID: 22663169
[TBL] [Abstract][Full Text] [Related]
5. Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States.
Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M
J Manag Care Spec Pharm; 2015 Oct; 21(10):965-72. PubMed ID: 26402395
[TBL] [Abstract][Full Text] [Related]
6. Is Infection an Independent Risk Factor for Venous Thromboembolism? A Population-Based, Case-Control Study.
Cohoon KP; Ashrani AA; Crusan DJ; Petterson TM; Bailey KR; Heit JA
Am J Med; 2018 Mar; 131(3):307-316.e2. PubMed ID: 28987552
[TBL] [Abstract][Full Text] [Related]
7. The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs.
Grosse SD; Nelson RE; Nyarko KA; Richardson LC; Raskob GE
Thromb Res; 2016 Jan; 137():3-10. PubMed ID: 26654719
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study.
Ashrani AA; Gullerud RE; Petterson TM; Marks RS; Bailey KR; Heit JA
Thromb Res; 2016 Mar; 139():29-37. PubMed ID: 26916293
[TBL] [Abstract][Full Text] [Related]
9. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study.
Heit JA; Kobbervig CE; James AH; Petterson TM; Bailey KR; Melton LJ
Ann Intern Med; 2005 Nov; 143(10):697-706. PubMed ID: 16287790
[TBL] [Abstract][Full Text] [Related]
10. The association of active cancer with venous thromboembolism location: a population-based study.
Tafur AJ; Kalsi H; Wysokinski WE; McBane RD; Ashrani AA; Marks RS; Crusan DJ; Petterson TM; Bailey KR; Heit JA
Mayo Clin Proc; 2011 Jan; 86(1):25-30. PubMed ID: 21193652
[TBL] [Abstract][Full Text] [Related]
11. Identifying in-hospital venous thromboembolism (VTE): a comparison of claims-based approaches with the Rochester Epidemiology Project VTE cohort.
Leibson CL; Needleman J; Buerhaus P; Heit JA; Melton LJ; Naessens JM; Bailey KR; Petterson TM; Ransom JE; Harris MR
Med Care; 2008 Feb; 46(2):127-32. PubMed ID: 18219240
[TBL] [Abstract][Full Text] [Related]
12. All-cause and disease-related health care costs associated with recurrent venous thromboembolism.
Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Hossou Y; Schein J; Kaatz S
Thromb Haemost; 2013 Dec; 110(6):1288-97. PubMed ID: 24085327
[TBL] [Abstract][Full Text] [Related]
13. Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.
Ashrani AA; Barsoum MK; Crusan DJ; Petterson TM; Bailey KR; Heit JA
Thromb Res; 2015 Jun; 135(6):1110-6. PubMed ID: 25891841
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for venous thromboembolism after acute trauma: A population-based case-cohort study.
Park MS; Perkins SE; Spears GM; Ashrani AA; Leibson CL; Boos CM; Harmsen WS; Jenkins DH; Bailey KR; Ballman KV; Heit JA
Thromb Res; 2016 Aug; 144():40-5. PubMed ID: 27284980
[TBL] [Abstract][Full Text] [Related]
15. Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.
Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
J Med Econ; 2011; 14(3):324-34. PubMed ID: 21506632
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for venous thromboembolism in nursing home residents.
Liebson CL; Petterson TM; Bailey KR; Melton LJ; Heit JA
Mayo Clin Proc; 2008 Feb; 83(2):151-7. PubMed ID: 18241624
[TBL] [Abstract][Full Text] [Related]
17. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study.
Heit JA; O'Fallon WM; Petterson TM; Lohse CM; Silverstein MD; Mohr DN; Melton LJ
Arch Intern Med; 2002 Jun; 162(11):1245-8. PubMed ID: 12038942
[TBL] [Abstract][Full Text] [Related]
18. Direct medical costs of polymyalgia rheumatica.
Kremers HM; Reinalda MS; Crowson CS; Zinsmeister AR; Hunder GG; Gabriel SE
Arthritis Rheum; 2005 Aug; 53(4):578-84. PubMed ID: 16082650
[TBL] [Abstract][Full Text] [Related]
19. Medical care costs associated with traumatic brain injury over the full spectrum of disease: a controlled population-based study.
Leibson CL; Brown AW; Hall Long K; Ransom JE; Mandrekar J; Osler TM; Malec JF
J Neurotrauma; 2012 Jul; 29(11):2038-49. PubMed ID: 22414023
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism in nursing home residents: role of selected risk factors.
Leibson CL; Petterson TM; Smith CY; Bailey KR; Ashrani AA; Heit JA
J Am Geriatr Soc; 2012 Sep; 60(9):1718-23. PubMed ID: 22880626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
